GI Dynamics (ASX:GID) said today that its EndoBarrier device won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System.
This status is the highest of 4 levels, which will bring in full reimbursement for the Lexington, Mass.-based company at the 143 participating hospitals. Payers at these hospitals will be required to cover the gaps in treatment costs for the EndoBarrier procedure, according to GI Dynamics.